ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,848.10
0.00%
S&P ASX All Technology
3,074.90
0.00%
Brent Oil
81.53
-1.11%
US Dollar vs AUD
1.5108
0.72%
Bitcoin
69,291.07
-1.20%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aclarion Inc (ACON)

  7. Aclarion Inc (ACON) News

ACON

Aclarion (ACON)

Aclarion Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACON
DateTimeSourceHeadlineSymbolCompany
25/04/202423:14GlobeNewswire Inc.Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back PainNASDAQ:ACONAclarion Inc
07/03/202408:09Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACONAclarion Inc
05/03/202400:00GlobeNewswire Inc.Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar DiscsNASDAQ:ACONAclarion Inc
28/02/202407:22GlobeNewswire Inc.Aclarion Announces Closing of $3.0 Million Public OfferingNASDAQ:ACONAclarion Inc
28/02/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
28/02/202402:46Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ACONAclarion Inc
27/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONAclarion Inc
27/02/202401:15GlobeNewswire Inc.Aclarion Announces Pricing of $3.0 Million Public OfferingNASDAQ:ACONAclarion Inc
24/02/202403:46Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
22/02/202409:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
22/02/202407:02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
07/02/202409:32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
06/02/202400:00GlobeNewswire Inc.Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic PartnershipNASDAQ:ACONAclarion Inc
02/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONAclarion Inc
02/02/202409:16Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONAclarion Inc
01/02/202409:26Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
29/01/202422:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
24/01/202401:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
23/01/202408:48Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ACONAclarion Inc
23/01/202400:00GlobeNewswire Inc.Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDNASDAQ:ACONAclarion Inc
18/01/202400:00GlobeNewswire Inc.Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan SolutionNASDAQ:ACONAclarion Inc
13/01/202408:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACONAclarion Inc
09/01/202400:00GlobeNewswire Inc.Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of NociscanNASDAQ:ACONAclarion Inc
05/01/202400:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONAclarion Inc
05/01/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
03/01/202404:00GlobeNewswire Inc.Aclarion Announces Reverse Stock SplitNASDAQ:ACONAclarion Inc
29/12/202322:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACONAclarion Inc
20/12/202308:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
12/12/202308:55Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ACONAclarion Inc
28/11/202300:00GlobeNewswire Inc.Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan ExamsNASDAQ:ACONAclarion Inc
 Showing the most relevant articles for your search:NASDAQ:ACON

Your Recent History

NASDAQ
VCBI
EU
ALLEC
Cogelec
COIN
BERRYBTC
ASX
BHPKOM
LSE
60UB
Fed.rep.n.32a
LSE
59RE
Westpac 27
LSE
HNSC
Hsbc Ngscon Etf
BIT
UB8C6N
Unicredit Bank
NASDAQ
EVSI
Envision Solar
USOTC
KRYAY
Kerry (PK)
NASDAQ
VRPX
Virpax Pharmaceuticals
LBNK
4JNETUSDT
4JNET
LSE
0QTV
Iar Systems Group Ab
EU
NL0015000RP1
Netherlands Domestic bon...
USOTC
CAETF
China East ED (PK)
COIN
RIMUST
MetaRim
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved